Christine Coyne
CIK 1861840 · Chief Commercial Officer · last filed 2025-07-03
Christine Coyne is a Chief Commercial Officer who has filed 3 SEC Form 4 insider transactions across 2 companies since 2021. The most recent filing, for ITRM, was dated Jul 3, 2025. Current disclosed insider exposure totals $246.2K across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$246.2K
2
3
$0
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Iterum Therapeutics plc (ITRM) Delisted | Chief Commercial Officer | — | $0.03 | — | $0 | 1 | 2025-07-03 |
| SCYX | Chief Commercial Officer | 58,200 | $4.23 | $246.2K | $0 | 2 | 2022-02-08 |
Recent Filings
3 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-07-03 | Iterum Therapeutics plc (ITRM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2022-02-08 | SCYX | Grant (A) | +43,200 | $0 | EDGAR |
| 2021-05-12 | SCYX | Grant (A) | +15,000 | $0 | EDGAR |